 |
Brian David Smith (born 1961) is a strategic management consultant, academic and author. His particular interests include the evolution of business models and competitive strategies in the life science sector, particularly pharmaceuticals and medical technology. His academic research on these topics informs both his consultancy and writing.
Smith was born in Hebburn in 1961, where he lived until he began his career.
Smith gained a BSc in Chemistry from Newcastle University in 1983 and spent the first years of his career working in pharmaceutical and medical technology companies as a research and development chemist. He then remained in the industry for a further 15 years working in various marketing and strategy roles. He became a qualified marketer in 1989 and served as the first non-academic examiner for the Chartered Institute of Marketing (CIM). Smith was heavily involved in the CIM for almost 30 years and acted as chair of its Levitt Group for senior and qualified marketers.
In 2003, Smith completed his PhD at Cranfield School of Management. His thesis, supervised by Professor Malcolm McDonald, was entitled The Effectiveness of Strategy Making Processes in Medical Markets and addressed the issue of why some life science firms make strong strategy and others do not.
Since 1998, Smith’s academic career has included teaching, research and PhD supervision at several universities.
Since 2011, Smith has been an adjunct professor at Bocconi University in Milan, Italy, where he teaches strategy the MIHMEP programme and research design on the DBA programme. Since 2013, he has also been also a visiting professor at the University of Hertfordshire, where he supervises a group of PhD students focused on the evolution of the life sciences industry. In September 2018, he became a module leader on the Middlesex University Pharmaceutical Industry MBA. [1] In March 2021, he was appointed as an external examiner to UCL’s Bioscience Entrepreneurship MSc.
Since 1998, Smith has, through his consultancy firm Pragmedic, advised many life science companies on how they can improve their competitive capabilities. His work focuses on the pragmatic application of strategic management science in the specific market and cultural context of this industry. Using his research into the Darwinian evolution of the industry, he focuses on how firms can adapt to their changing sociological and technological environment.
Smith’s current research focus is the application of Darwinian Evolution to the business models in the life sciences industry. His work builds on prior work, including his PhD research, concerning the effectiveness of strategy making in life science companies, how firm create market insight and the connection between strategy and commercial outcomes.
This research has led to Smith’s publication of more than 300 articles and papers and 7 books. [2] Smith’s foremost publications include his books Darwin’s Medicine (2017) and The Future of Pharma (2011). Smith was also founding editor for the peer reviewed Journal of Medical Marketing. [3] His own peer reviewed publications include:
Marketing is the act of satisfying and retaining customers. It is one of the primary components of business management and commerce.
In the field of management, strategic management involves the formulation and implementation of the major goals and initiatives taken by an organization's managers on behalf of stakeholders, based on consideration of resources and an assessment of the internal and external environments in which the organization operates. Strategic management provides overall direction to an enterprise and involves specifying the organization's objectives, developing policies and plans to achieve those objectives, and then allocating resources to implement the plans. Academics and practicing managers have developed numerous models and frameworks to assist in strategic decision-making in the context of complex environments and competitive dynamics. Strategic management is not static in nature; the models can include a feedback loop to monitor execution and to inform the next round of planning.
Marketing management is the strategic organizational discipline that focuses on the practical application of marketing orientation, techniques and methods inside enterprises and organizations and on the management of marketing resources and activities. Compare marketology, which Aghazadeh defines in terms of "recognizing, generating and disseminating market insight to ensure better market-related decisions".
Marketing strategy refers to efforts undertaken by an organization to increase its sales and achieve competitive advantage. In other words, it is the method of advertising a company's products to the public through an established plan through the meticulous planning and organization of ideas, data, and information.
Business strategies can be categorized in many ways. One popular method uses the typology put forward by American academics Raymond E. Miles and Charles C. Snow in their 1978 book, Organizational Strategy, Structure, and Process.
Michael Eugene Porter is an American businessman and professor at Harvard Business School. He was one of the founders of the consulting firm The Monitor Group and FSG, a social impact consultancy. He is credited with creating Porter's five forces analysis, a widely-used management framework. He is generally regarded as the father of the modern strategy field. He is also regarded as one of the world's most influential thinkers on management and competitiveness as well as one of the most influential business strategists. His work has been recognized by governments, non-governmental organizations and universities.
Design management is a field of inquiry that uses design, strategy, project management and supply chain techniques to control a creative process, support a culture of creativity, and build a structure and organization for design. The objective of design management is to develop and maintain an efficient business environment in which an organization can achieve its strategic and mission goals through design. Design management is a comprehensive activity at all levels of business, from the discovery phase to the execution phase. "Simply put, design management is the business side of design. Design management encompasses the ongoing processes, business decisions, and strategies that enable innovation and create effectively-designed products, services, communications, environments, and brands that enhance our quality of life and provide organizational success." The discipline of design management overlaps with marketing management, operations management, and strategic management.
IMS Health was an American company that provided information, services and technology for the healthcare industry. IMS stood for Intercontinental Medical Statistics. It was the largest vendor of U.S. physician prescribing data. IMS Health was founded in 1954 by Bill Frohlich and David Dubow with Arthur Sackler having a hidden ownership stake. In 2010, IMS Health was taken private by TPG Capital, CPP Investment Board and Leonard Green & Partners. The company went public on April 4, 2014, and began trading on the NYSE under the symbol IMS. IMS Health was headquartered in Danbury, Connecticut.
The resource-based view (RBV), often referred to as the "resource-based view of the firm", is a managerial framework used to determine the strategic resources a firm can exploit to achieve sustainable competitive advantage.
The Association of the British Pharmaceutical Industry (ABPI) is the trade association for over 120 companies in the UK producing prescription medicines for humans, founded in 1891. It is the British equivalent of America's PhRMA; however, the member companies research, develop, manufacture and supply medicines prescribed for the National Health Service.
IQVIA, formerly Quintiles and IMS Health, Inc., is an American Fortune 500 and S&P 500 multinational company serving the combined industries of health information technology and clinical research. IQVIA is a provider of biopharmaceutical development, professional consulting and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including investment strategy and management consulting services. It has a network of more than 88,000 employees in more than 100 countries and a market capitalization of US$49 billion as of August 2021. As of 2023, IQVIA was reported to be one of the world's largest contract research organizations (CRO).
The following outline is provided as an overview of and topical guide to marketing:
A seeding trial or marketing trial is a form of marketing, conducted in the name of research, designed to target product sampling towards selected consumers. In the marketing research field, seeding is the process of allocating marketing to specific customers, or groups of customers, in order to stimulate the internal dynamics of the market, and enhance the diffusion process. In medicine, seeding trials are clinical trials or research studies in which the primary objective is to introduce the concept of a particular medical intervention—such as a pharmaceutical drug or medical device—to physicians, rather than to test a scientific hypothesis.
Complementary assets are assets that when owned together increase the value of the combined assets. It is defined as “the total economic value added by combining certain complementary factors in a production system, exceeding the value that would be generated by applying these production factors in isolation.” Thus two assets are said to be complements when investment in one asset increases the marginal return on the other. On the contrary, assets are substitutes when investment in one does not affect the marginal return of the other.
Tim Ambler was a British organizational theorist, author and academic on the field of Marketing effectiveness. Ambler featured on Marketing's list of the 100 most powerful figures in the industry. He is cited by the Chartered Institute of Marketing as one of the top 50 marketing experts in the world
Sven A. Haugland is a Norwegian organizational theorist and Professor of industrial marketing and strategy at the Norwegian School of Economics, known for his work on marketing in the service industry, and measuring Strategic alliance performance.
ZS Associates is a management consulting and professional services firm focusing on consulting, software, and technology. Headquartered in Evanston, Illinois, it provides healthcare, private equity, and technology services. The firm was founded in 1983 by two professors at Northwestern University who developed sales force alignment models using the world’s first personal-computer-aided territory mapping system.
Raymond-Alain Thietart is a French business school professor. He is the author of eight books on strategy and management and over a hundred articles in the same field. His research and teaching focus on organization theory and strategic management.
Anil K. Gupta is an American academic specializing in business strategy. He holds the Michael D. Dingman Chair in Strategy, Globalization, and Entrepreneurship at University of Maryland’s Robert H. Smith School of Business.
Zillur Rahman is a professor of management studies at the Indian Institute of Technology Roorkee in Roorkee, Uttarakhand, India.
| International | |
|---|---|
| National | |
| Other | |
